Ghent University Academic Bibliography

Show Sort by

Your filters: cql: keyword exact "NATURAL-KILLER-CELL"

Add to list
- Journal Article
- A1
- open access
AUGMENT : a phase III study of lenalidomide plus rituximab versus placebo plus rituximab in relapsed or refractory indolent lymphoma

John P Leonard, Marek Trneny, Koji Izutsu, Nathan H Fowler, Xiaonan Hong, Jun Zhu, Huilai Zhang, Fritz Offner (UGent) , Adriana Scheliga, Grzegorz S Nowakowski, et al.

(2019) JOURNAL OF CLINICAL ONCOLOGY. 37(14). p.1188-1199
Add to list
Porcine reproductive and respiratory syndrome virus infection is associated with an increased number of Sn-positive and CD8-positive cells in the maternal-fetal interface

Uladzimir Karniychuk (UGent) , Ward De Spiegelaere (UGent) and Hans Nauwynck (UGent)

(2013) VIRUS RESEARCH. 176(1-2). p.285-291
Add to list
Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR₃A and FCGR₂A polymorphisms

Hervé Ghesquières, Guillaume Cartron, John Francis Seymour, Marie-Hélène Delfau-Larue, Fritz Offner (UGent) , Pierre Soubeyran, Aurore Perrot, Pauline Brice, Réda Bouabdallah, Anne Sonet, et al.

(2012) BLOOD. 120(13). p.2650-2657
Add to list
Continuous CD27 triggering in vivo strongly reduces NK cell numbers

Veerle De Colvenaer (UGent) , Sylvie Taveirne (UGent) , Jörg Hamann, Alex M de Bruin, Magda De Smedt (UGent) , Tom Taghon (UGent) , Bart Vandekerckhove (UGent) , Jean Plum (UGent) , René van Lier and Georges Leclercq (UGent)

(2010) EUROPEAN JOURNAL OF IMMUNOLOGY. 40(4). p.1107-1117

Academic Bibliography

AUGMENT : a phase III study of lenalidomide plus rituximab versus placebo plus rituximab in relapsed or refractory indolent lymphoma

Porcine reproductive and respiratory syndrome virus infection is associated with an increased number of Sn-positive and CD8-positive cells in the maternal-fetal interface

Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR₃A and FCGR₂A polymorphisms

Continuous CD27 triggering in vivo strongly reduces NK cell numbers

Contents

Support

Contact